Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-28

Clinical Trial Update: Mesenchymal Stemcells for Radiation Induced Xerostomia [Phase 2]

View source ↗

Summary

Phase 2 trial of mesenchymal stem cells for radiation-induced xerostomia completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Xerostomia | Phase 2 | Status: COMPLETED | Results posted: 2022-12-28